Format

Send to

Choose Destination

See 1 citation found by title matching your search:

J Cell Physiol. 2020 May;235(5):4587-4593. doi: 10.1002/jcp.29335. Epub 2019 Oct 23.

Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia.

Author information

1
GIRO-KLINIC, Girona, Spain.
2
Department of Public Health, Experimental Medicine and Forensics, Center for Health Technologies, University of Pavia, Pavia, Italy.
3
Private practice of Plastic Surgeon, Rome, Italy.
4
Biomedical Research Institute i2e3, Barcelona, Spain.
5
Department of R&D, Human Brain Wave, Turin, Italy.
6
Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

Abstract

Regenerative medicine is a multidisciplinary field that combines engineering and life science principles to promote regeneration, potentially restoring the physiological condition in diseased tissues. Specifically, the developments of complex grafts enhance the intrinsic regenerative capacity of the host by altering its environment. Autologous micrografts obtained through Rigenera® micrografting technology are able to promote derma and bone regeneration. Androgenetic alopecia (AGA) leads to a progressive thinning of scalp hair affecting 60-70% of the adult population worldwide. Pharmacological treatment offers moderate results and hair transplantation represents the only permanent treatment option. The aim of this study was to demonstrate the role of dermis micrografting in the treatment of AGA by clinical and histological evaluations after 4, 6, and 12 months. Hair growth and density were improved at all indicated times. Those outcomes were also confirmed by the TrichoScan® analysis, reporting an increase of total hair count and density with an increase and reduction of anagen and telogen phases, respectively. Scalp dermoscopic analysis showed an improvement of hair density and histological analysis indicated a clear amelioration of the scalp, development of hair follicles, and a beginning of cuticle formation. Collectively, those results suggest a possible use of the micrografts as a novel therapeutic option in the management of AGA.

KEYWORDS:

androgenetic alopecia; micrograft; regenerative medicine

PMID:
31643084
DOI:
10.1002/jcp.29335

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center